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Research Repott

Chronic Dermal Ulcer Healing Enhanced with
Monophasic Pulsed Electrical Stimulation

The purposes of this randomized, double-blind, multicenter study were to compare healing of chronic dennal uicen· treated with pulred electrical stimulation
with healing of similar wounds treated with sham electrical stimulation and to
evaluate patient tolerance to the therapeutic protocol. Pony-seven patients, aged
29 to 91 years, with 50 Stt@! !1, //J, and N ulctm were randomly assigned to either a treatment group (n=26) or a control (sham treatment) group (n=24).
Treated wounds received 30 minutes of pulsed cathodal electrical stimulation
twice daily at a pulse frequency of 128 pulses per second (pps) and a peak amplitude of 29.2 mA if the wound contained necrotic tissue or any drainage that was
not serosanguinous. A saline-moistened nontreatment electrode was applied 30.5
em (12 in) cephalad from the wound. This protocol was continued for 3 days
after the wound was debrided or exhibited serosanguinous drainage. Thereafter,
the polarity of the treatment electrode on the wound was changed every 3 days
until the wound progressed to a stt@! II classification. The pulse frequency was
then reduced to 64 pps, and the treatment electrode polarity was changed daily
until the wound was healed. Patients in the wntrol group were treated with the
same protocol, except they received sham electrical stimulation. After 4 weeks,
wounds in the treatment and control groups were 44% and 67% of their initial
size, respectively. The healing rates per week for the treatment and control groups
were 14% and 8.25%, respectively. The results of this study indicate that pulsed
electrical stimulation has a beneficial effect on healing stage 11, Ill, and N
chronic dennal ulcer.;. {Feedar ]A, Kloth LC, Gentzkow GD. Chronic dermal ulcer
healing enhanced with monophasic pulsed electrical stimulation. Pbys Ther.
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Since the mid-1900s, therapeutic
doses of electrical current have been
shown to augment healing of chronic
wounds in human subjects and induced wounds in animal models. 1...s
Studies of cell cultures have shown
that electrical fields can influence the
migratory, proliferative, and functional
capacity of cells involved in the heal·
ing processY-14 Other studies have
rep:med measurements of injury
potentials, skin battery voltages, and
wound lateral voltage gradients that
have been theorized to trigger bioelectrical repair and enhancement of

This article was submilled}uly 27, 1990, and was accepted May 14, 1991.
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wound healing. 15,J6 If electrical signals
play a role in the stimulation of
wound repair, then exogenous application of electrical current to chronic
wounds could be expected to mimic
the body's bioelectrical currents and
enhance tissue healing processes. Repons from numerous clinical and experimental studies provide evidence
in support of this idea.l-14
Since 1969, a number of publications
reJated to the clinical use of electrical
stimulation for treatment of chronic
dermaJ ulcers have reported accelerated rates of heaJing of 13% to 46%
per week during an average of 6.6
weeks compared with small numbers
of control wounds that healed between 5% and 15% per week.l-4 In all
of these studies, the polarity of the
wound cledrode was changed periodically during the study period. Two of
these studies reported using either 4
hours3 or 45 minutes 4 of electrical
stimulation treatment per day, 5 days
per week; the other two studies rejX)rted using 6 hours of stimulation
per day, 7 days per week.1,2 All of
these studies delivered 200 to 1,000
IJ.A of either direct currentl-3 or timeavernged pulsed current" to the
wound tissues.
Additional support for using direct
current or time-averaged pulsed current electrical stimulation to accelerate healing of chronic dermal ulcers
is provided by the results of numerous animal studies. Although there is
lack of agreement on the effects of
polarity, many of these studies have
reported that electrical stimulation
from direct current'>-7 and timeaveraged pulsed current devicess produces faster closure'HI and greater
tensile strength of the scar tissue in
acute induced wounds than in control
wound<>. Other experimentaJ animal
studies 1s-Is have confirmed that weak
cathoda1 electrical stimulation solubilizes clotted blcxx:l, which provides
support for the clinical observation
that cathodal direct current stimulation facilitates debridement of necrotic wound tissue consisting primarily of coalesced blood elements.
Recently, studies on induced wounds
in pigs have reported that electrical

stimulation can improve the survival
of skin flaps 19 and significantly increase the rate of wound epithelialization' and contraction20·2 1 and the proliferation of fibroblasts.2o
Some of these findings are in turn
supported by in vitro studies in
which isolated epidermal cells, cell
clusters, and cell sheets demonstrated galvanotaxis in migrating
toward the cathodeY- 10 A galvanotaxic effect on other cells involved
in the tissue-healing process has
been demonstrated in a number of
other studies as well. Macrophages
have been shown to migrate toward
the anode, 11 whereas neutrophils
have been observed to migrate
toward both the anode and the cathode.n.n Monguio 12 and Dineur, 1 4
however, have reported that neutrophilic leukocytes migrate toward the
cathode in regions in which infection or inflammation are present,
and Eberhardt et al22 have found
that electrical stimulation increases
the relative number of neutrophilic
leukocytes in human skin exudate.
Weiss et aJ23 have indicated that,
following exposure to exogenous
current, there is evidence of a reduction in human tissue mast cells.
Such cells are present in increased
numbers in a variety of fibrotic disorders including keloids. 2 3 Weiss
and colleagues speculate that the
effect of electrical stimulation on
scar formation may be due to a decrease in mast cell migration.
That cell functionaJ capacity may be
influenced by changes in potential is
supported by cell culture studies in
which erythrocytes and fibroblasts
were exposed to electrical currents.
Harrington and Becker24 have shown
that frog erythrocytes subjected to
electrical current synthesize ribonucleic acid and protein, whereas erythrocytes not exposed to current do not
produce appreciable amounts of macromolecules. In view of the significant
differences between human and frog
erythrocytes, this effect may not relate
to the clinical use of electrical stimulation. Bassett and Hernnann 25 exposed Green's 3T-6 fibroblasts in culture to continuous direct current and
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demonstrated increases in deoxyriOOnucleic acid (DNA) production and
collagen synthesis after 14 days. By
interrupting the direct current, they
found that DNA production increased
20% and that collagen synthesis increased 100%.
Bourguignon and Bourguignon26 reported that high voltage pulsed current stimulation of normal human
fibroblasts in culture led to increased
DNA production and protein synthesis. Maximum synthesis was noted to
occur in cells lying in close proximity
to the cathcxle. This observation is
consistent with previous evidence
linking a proliferative response to
electronegativity.
Growth factors play an important role
in wound healing, and the trnnsformation of growth factor-~ has a fundamental role in collagen synthesis. Falanga et a1~ have demonstrated that
dermal fibroblasts in culture, stimulated with pulsed current at 100
pulses per second (pps) and 100 V,
had increases in the expression of
receptors for transforming growth
factor-~ that were six times greater
than those of control fibroblasts.
The effects of exogenous currents on
wound tissues and cells may enhance
the effeLts of the "skin battery," which
is believed to reside within the epidermis and to augment wound healing. Foulds and Barker2s have demonstrated that a voltage is maintained
across the epidermis. They report that
the outer surface of skin is negatively
charged with resped to the positively
charged dermis. The average voltage
measured on the surface of human
skin is -23.4 m¥. 15 In wounded
mammalian skin, wound currents
have been shown to genernte lateral
intraepidermal voltage gradients surrounding the wound as a very narrow
1-mm band.I 6 At 0.25 mm from the
wound edge, the amplitude of this
voltage gradient falls off about threefold. 29 Interestingly, corresponding
decreases in epidermal cell migration
also occur a very short distance from
the wound edge.

64() /13

The purposes of this clinical smdy
were (1) to compare healing of
chronic dennal ulcers treated with
pulsed electrical stimulation with
healing of similar wounds treated
with sham elearical stimulation and
(2) to evaluate patient tolerance to the
therapeutic protocol We hypothesized that chronic dermal ulcers
treated with pulsed elearical current
would heal faster and more completely than ulcers treated with sham
electrical stimulation.

-

T able 1. Palienl and Ulcer Characteristics

Control Group

Treatment
Group

(n=24)

(n=26)

Total

Age {y)
X

60.7

66.6

63.8

so

19.2

15.6

17.5

Range

30-90

29-91

29--91

Male

50.0

538

52.0

Female

50.0

46.2

48.0

II

2

0

2

Ill

17

22

39

IV

s

4

9

24

26

50

18

17

35

3

6

9

2

3

5

24

26

50

Hlp/ISchium

6

8

14

Sacrum/coccyx

9

4

13

Sex(%)

Sub}octs
Fifty-nine patients (67 wounds) at nine
investigational sites participated in
the study. Eight patients each had 2
wounds, which were separately randomized and entered into the study.
Of the initial 59 patients, the data fOr
12 patients (17 wounds) were not included in the data analysis. Four
wounds were excluded because the
patients did not complete the 4-week
study, 4 because the wound size did
not meet entry criteria, 3 for uninterpretable measurements, and 6 because
of omitted or incorrect treatments. The
data for the remaining 47 patients (50
wounds [26 in the treatment group,
24 in the control group]) were thus
available for the data analysis.

Stage

Total
Etiology
Pressure sore
Surgical
vascular
Traumatic
Total

0

Location

Leg
Foot

6

Othera

5

6

s

11

2

4

6

24

26

50

<1 mo

20.8

23.1

22.0

1-3 mo

16.7

269

22.0

Total
Duration (%)

Patiem ages ranged from 29 to 91
years. The mean ages of the patients
in the treatment and control groups
were 66.6 (SD=15.6) and 60.7 (SD
= 19.2) years, respectively. The patients (52% male, 48% female) were
equally distributed between the treatment and control groups (Tab. 1).
The subjects in this study were patients with stage II, Ill, or N chronic
dennal ulcers. There were no age or
sex restrictions for participation in the
study. The patients were participants
in the study for 4 week<;, because we
believed that some measurable effect
on healing would occur in that
amount of time. Patients were excluded from the study if they had cardiac pacemakers, peripheral vascular
disease disposing them to thrombosis,
or active osteomyelitis or if they were
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3-6 mo

16.7

7.7

12.0

6--12 mo

25.0

23.1

24.0

>12 mo

20 8

19.2

20.0

~Head,

back, axilla.

pregnant or receiving long-term radiation therapy, steroid therapy, or chemotherapy. Following the initial evaluation to determine whether the
wound and the patient met the selection criteria, each patient signed an
infonned consent form. Patients were
then randomly assigned to either an
electrical stimulation treatment group
or a control (sham electrical stimulation) group.

Wound Selection

Wounds could be stage II, Ill, or N
pressure sores; ulcers caused by vascular insufficiency; or wound<; caused
by trauma or surgery. The wound
stages were defined as follows: stage
II wounds=full-thickness skin defects
extending into the subcutaneous tissue; stage III wounds=defects extending into the muscle; and stage N
wounds=defects extending into the
bone or the joint.30 Wounds could be
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64pps

j-.132 J~,a-1

J .____I_I L~Im·
15.5 mt

H32~

128 pps

Jl'-----'I L
I--

7.74 mo

----.j

T

29.2 mA

1

Procedure

Figure 1. Duration and amplitude charaden'stics of the monophasic pulsed current at frequencies of64 and 128 pulses per second (pps).
between 4 and 100 cm 2 in size.
Wounds excluded from the study

were those with uninterpretable measurements (ie, measuremems ob-

tained when investigators were inconsistent in how they measured the
wound) and those that were completely occluded by eschar, those that
were hemorrhaging, or those of cancerous etiology.
Of the 50 wounds represented in the
data analysis, 2 were stage II wounds,
39 were stage III wounds, and 9 were
stage N wounds (fab. 1). Both stage
II wounds were in the control group.
Table 1 also shows the etiology, location, and duration of aJI ulcers. The
etiologies of the wounds (35 pressure
sore, 9 surgical, 1 vascular, and 5 traumatic) were approximately equivaJent
in the two groups. The locations of
the ulcers were hip/ischium (n=14),
sacrum/coccyx (n=13), leg (n=6),
foot (n= 11), and other (n=6), and
these locations were approximately
equally distributed in the two groups.
Duration of the ulcer was also equiva-

the output pulse through a 1-kf! load
at 29.2 V (output dial set at 35). The
output pulse was observed to have
instantaneous rise and decay times of
the waveform leading and trailing
edges, resulting in a rectangular pulse
with an amplitude of 29.2 rnA and a
duration of 132 IJ.S. At this resistive
load, the current per pulse delivered
to the stainless steel, sponge-covered
electrodes of the active stimulaton.
was 3.9 11-C. For the purpose of this
study, pulse frequencies of 128 and
64 pps were used. At these frequencies, the pulse period was determined
to be 7.74 and 15.5 ms, respectively
(Fig. 1). Thus, the accumulated pulse
charge was 499.2 ,.,..c;s at the higher
pulse frequency and 249.6 !J.C/s at the
lower frequency.

lent in the groups (ie, 22%=<1
month, 22%=1-3 months, 12%=3--6
months, 24%=6---12 months, and
20%=>1 year). Initial wound size
was a mean of 14.64 cm 2 in the treatment group and 16.93 cm 2 in the control group. There were more patients
with tunnels or undermining in the
treatment group than in the control
group (26.9% versus 16.7%, rcspc"Ctively). There were no significant differences (P< 10) between the treatment and control groups for any of
the patient, ulcer, or wound care
characteristics. TherefOre, the randomization procedure appears to
have successfully provided comparable treatment and control groups.

Instrumentation
The electrical stimulation device used
in this study was the Vara;PuJse® stimulator,* which delivers monophasic
pulsed current. (Note: the Vara!Pulse®
stimulator is no longer commercially
available.) A Tektronix model 2430
digital oscilloscope t was used to pass

Staodym•mics Inc, 1225 Florida Ave. PO Box 1379, Lungmom, CO 80502·1379.

0

trektroni>! Inc, p0 Box 500, Beavenon, OR 97077.
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This study was conducted as a randomized, double-blind clinical trial.
First, a randomization list was established for each center by the central
study director. Each consecutive numbered patient at each center was then
randomly assigned to either a treatment group, which used an active
stimulator, or a control group, which
used a stimulator that had been modified to pnx:iuce no output current.
The randomization procedure was
controlled to ensure that equal numbers of patients were assigned to the
treatment and control groups at each
center. The clinical investigators did
not have access tu the randomization
lists and therefore did not know
whether a particular device was active
or inactive. Neither the investigators
nor the patients were aware of which
type of device was used for a particular wound during the 4-week study
period. Patients in the treatment and
control groups received identical
treatments during the study period,
except for the rype of stimulator (ie,
active versus inactive) that was used.
A few patients reported a tingling sensation; however, this sensation was
reponed by patients in both groups,
and we do not believe that it comprOmised the blinding procedure. All
investigators agreed to comply with
the blinding procedure, and monitor-

642!15
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T able 2. Summary of Wound Length-Width Products for Pallents in 1::/ectrical St(mu/ation Treatment Group

Wound
No.

lniUal Wound Size
(om')

(n=26r

Percentage of lniUal Length-Width Product
Week 1

Waek2

Week3

Week4

Last Week

Total No.
of Weeks

TR-01

5.00

75.00

75.00

75.00

72.00

12.00

15

TR..02

15.64

62.66

35.17

21.74

10.55

160

7

TR-03

21.50

87.72

88.88

102.00

92.09

70.70

14

TA-04

44.00

93.81

75.00

54.09

39.45

509

8
5

TR-05

864

100.00

81.48

41.67

6.94

2.78

TA-06

600

33.33

30.00

8.33

4.17

417

4

TR-07

35.38

62.41

21.20

1767

1.41

006

10

TR-08

7.00

85.00

91.14

87.43

75.00

0.71

15

TR-09

585

76.92

85.47

51 28

68.38

68.38

4

TR-10

9.89

84.52

54.60

17.69

0.40

0.40

4

TR-11

4.00

5850

2800

31.50

21.00

250

7

TR-12

4.60

66.52

33.91

45.65

48.04

48.04

4

TR-13

12.50

100.00

68.00

57.60

70.56

12.00

14

TR-14

4.80

76.67

5417

31.25

15.63

12.50

8

TA-15

40.50

95.56

90.25

92.37

6644

25.93

8

TA-16

5.44

94.12

77.21

82.72

62.13

62.13

4

TR-17

16.25

59.08

40.62

15.88

4.62

0.37

6

TR-18

4.95

75.76

24.24

45.45

34.14

34.14

4

TR-19

800

78.75

80.00

75.00

75.00

50.00

8

TR-20

9.00

75.00

35.56

31.11

18.33

18.33

4

TR-21

22.80

88.33

105.61

154 61

62.72

000

12

TR-22

21.00

100.00

77.38

74.57

49.71

35.00

14

TR-23

18 45

95.39

82.38

65.04

6640

57.13

5

TR-24

17.39

60.72

31.74

19.84

19.84

4

TR-25

28.00

125.00

125.00

100.00

87.50

0.00

15

TR-26

4.20

94.29

94.29

6857

68.57

6857

4

X

14.65

81.77

65.97

5692

43.89

23.55

7.96

SD

11.37

18.28

27.34

33.37

29.47

24.95

4.13

N

26

25

26

26

26

26

"Note tnit.Jal wound size is given as length-width produG (tn square centimeters). Weekly
wound size.

ing did not reveal any evidence that
this procedure had been compromised. To funher ensure that the clinical trials were blinded, the pen;ons
who administered the treatment~
were different from those who obtained the measurements. To ensure
consistency of the measurement technique across clinical sites, a nurse
specialist trained all of the personnel
who obtained the measurements and
monitored all clinical sites during the
study by periodic site visitations. Furthermore, the same person at each
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measuremen~~

clinical site took all of the measurements on a given patient throughout
the study.
Each wound was assessed at the beginning of the smdy before the active
or sham stimulation protocol was begun. A wound/patient clinical hi~tory,
including wound etiology, prior treatment received, and medications being
taken, was recorded. Wound duration
information was obtained by patient
self-report when not available from
patient records.

26

are gtvcn as the percentage of the initial

Once a week, the wound appearance
(eg, color, presence or absence of
necrotic and/or granulation tissue)
was documented, and length and
width me<ll>uremems of the wound
were recorded. A color photograph
was taken every 2 weeks to provide a
permanent record and for monitoring
purposes. The length of the wound
was recorded as the wound's largest
diameter, and the width of the wound
was recorded as the wound's largest
diameter perpendicular to the length.
This measurement technique is sim-
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T able 3. Summary of Wound Length-Width Products for Patients in Sham Treatment Group (n=24)"
Wound
No.

lnlllal Wound Size
(om')

Percentage of Initial Length-Width Product
Week 1

Woek2

Waek3

WHk4

9000

SH-{)1

6.00

83.33

62.50

84.00

66.67

38.89

21 78

SH-Q2

4.50

SH-03

12.25

SH.Q4

5.25

166.67

778
5.31

45.71

178.67

178 67

178.57

SH<l!i

7.50

90.00

66.67

50.00

21.33

SH-06

12.25

96.65

100_00

as 11

8359

SH-07

3000

100.00

14000

110.00

108.33

SH-08

12.25

143.92

153.96

130.29

139.59

SH-09

6.40

61.25

26.56

3.28

0.00

SH-10

74.70

94.65

96.72

78.98

81.39

SH-11

67.50

88.15

57.04

38.30

6.40

SH-12

8.40

95.24

72.38

5357

29.76

SH-13

5.10

SH-14

5.55

SH-15

20.40

117.65

29.41

37.65

100.00

97.30

9081

100.90

80.88

81.57

66.18

64.12

28.13

SH-16

40.00

78.75

60.00

SH-17

5.28

87.12

79 55

57.95

51.52

SH-18

4.05

98.77

72.59

5778

6568
142.01

SH-19

6.76

99.41

107.84

107.84

SH-20

41.48

87.22

85.34

8088

90.89

SH-21

6.21

69.57

69.57

63.77

57.97

SH-22

10.50

100.00

95.24

76.19

81.71

SH-23

4.00

110.00

45.00

38.50

SH-24

10.00

100.00

9000

90.00

99.00

x

16.93

9606

86.74

73.04

67.18

SD

1979

23.51

36.09

37.54

47.32

N

24

21

23

23

24

~Note:

Inilial wound size is given as length-width product (in square centimeter;). Weekly measurements are given as the percentage of the in mal
wound size.

pie, reproducible, and easy to accomplish at the bedside. In addition, evaluators were required to illustrate the
position of these measurements on a
wound diagram. Thus, the primary
measure of wound healing used in
the study was the measurement of
wound size.
The protocol consisted of two 30minute active or sham electrical stimulation sessions, given 7 days a week
The protocol was based on those
used in previous clinical studiesl--4
and consisted of the following steps:

I. Irrigation of the wound bed with

saline solution before each treatment and maintenance of a salinemoistened wound environment
between treatments.
2. Application of clean, salinemoistened gauze sponges directly
over stage II wounds or into stage
III and IV wounds.

3. Application of a 16-x 16-cm nontreatment sponge electrode moistened with tap water and secured to
the skin a minimum of 30.5 em
(12 in) from the wound site.

Physical Therapy;Volume 71, Number 9/September 1991

4. Application of a 7.5-X 7.5-cm treatment sponge electrode on top of
the saline-moistened gauze covering the wound and secured in
place.
5. Vara/Pulse® stimulation controls
were set at a pulse frequency of
128 pps and at an amplitude of 35
mA, and the polarity switch was set
to deliver a negative charge to the
electrode placed on the wound.

6. Using these stimulus variables, two
30-minute treatments were given
daily Cl days a week), with a mini-

644/17
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100

..
!.

----

-- 1-............
-- -- --

1!

~

70

li
.5

"

who measured the wounds were unaware as to whether the electrical
stimulator was an active or an inactive
device.

'ii

...... SHAM

-o-

---

Patients in the control group, after
completing the 4-week trial, were
then given the opportunity to switch
to an active stimulator. Patients who
chose to cross over to an active stimulator were monitored and treated in
the same manner as during the pre·
ceding 4-week trial The patients who
received active electrical stimulation
were treated for at least 4 weeks or
until wound closure occurred. All
patients' wounds were assessed at
weekly intervals for 4 weeks after the
study protocol was terminated.

ST1M

- --- --- ---

•.• .
i!
I- .
I ...

Data Analysis

E

~

z

Data from the treatment and control
groups were statistically analyzed to
10
determine comparability of the
groups with regard to factors that
might influence outcome. We ana0
0
3
lyzed the following characteristics:
sex,
age, wound stage, wound duraTreatment (w)
tion, wound etiology, wound location,
Figure 2. Mean percentage of reduction in wound size with standard error for each presence of tunnels or undermining,
of 4 weeks of treatment for the electrical stimulation group (~TIM) and the sham efectn'cal presence of eschar, initial wound
measurements (length, width, and
stimulation group (SffAM).
length-width product), patient mobility status (bedridden, wheelchair user,
mum of 4 hours and a maximum of
the p.::>larity of the wound elecambulatory), previous and concurrent
8 hours between treatment sessions.
trode was alternated daily until the
treatments of wound, systemic condiwound closed. On the average,
tions, concurrent treatment for other
7. In this study, only 10% of each
{XIIarity of the wound electrode
conditions, and inpatient versus outwas changed six times in the 28group received surgical or whirlpatient treatment. The statistical analypool debridement. The wounds
day period.
sis involved the use of the chi-square
not requiring surgical or whirlpool
test (with the Yates continuity correcdebridement were treated with
8. If a wound initially was a clean
tion for fourfold tables) for discrete
electrical stimulation or dressings
stage II wound, treatment was
factors such as wound stage or locastarted as described in step 7.
(generally for about 7 days) until
tion and the two-sample t test for
the wound spontaneously debrided
quantitative measures such as wound
or a serosanguinous drainage apPatients residing in skilled nursing
duration or initial size.
facilities were treated daily by a health
peared. In either case, negative
care practitioner (ie, physical therapolarity of the wound electrode
Wound length and width were meawas continued for 3 additional
pist, registered nu~e. physician) who
sured at weekly intervals during the
was a member of the study team for
days. Thereafter, the polarity of the
treatment period. Because wound
that facility. For outpatients who lived
wound electrode was changed evmeasurement values were obtained
ery 3 days until the wound healed
at home, either the patient or a family
for
both treatment and control groups
member was trained to apply the
to a stage II classification. At that
each
week for 4 weeks, we used the
time, it was felt that an excessive
stimulator each day. Eight patients in
wound
size data (defined as the
charge delivered at 128 pps might
each group received their treatment
prcxiuct) at the 4-week
length-width
overstimulate the wound tissue;
as outpatients. In all instances, health
point
as
the
definitive
data for comtherefore, the pulse frequency was
care practitioners obtained the wound
parison
purposes.
A
reduction
in the
decreased to 64 pps. In addition,
measurements each week. Evaluators

•
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Figure 3. Comparison of wound healing in electrical stlmuJation group (SFJM)
and sham electrical stimulation group (SHAM) after 4 weeks of treatment.
length-width product was considered
an indication of wound hea1ing.

other factors that might influence the
outcome of wound healing.

These changes in wound size were
assessed by expressing each wound's
length-width product at each week as
a percentage of its initial length-width
prcxluct, allowing comparisons of all
wounds, regardless of their absolute
size. The means of the individual percentageS for each group's wounds
were compared, using the two-sample
t test (one-tailed) to evaluate the null
hypothe~is of no treatment differences. For the patients in the control
group who crossed over to active
stimulati.on, a paired t test (one-railed)
was used to compare the wound data
obtained during the 4 weeks of active
treatment with the wound data obtained during the 4 weeks of sham
treatment A stepwise multipleregression analysis was perfonned
using the week-4 wound size as the
dependent variable to evaluate the
significance of treatment group in
wound healing, while adjusting for

Results
Tables 2 and 3 present summaries of
the wound length-width products during the course of the study for all
wounds. The measurements for each
week are expressed as a percentage
of the initial wound size. After 4
weeks, the 26 wounds in the treatment group were 44% of their original size, whereas the 24 wounds in
the control group were 67% of their
initial size (P<.02). These differences
represent an average healing rate of
14% per week for the treatment
group versus 8.2"5% per week for the
control group. r>;one of the treatment
group's ulcers increased in size; 5 of
the control group's ulcers increased
in size. Figure 2 graphically demonstrates the substantial difference in
healing between the groups.
Only two variables, presence of tunnels or undennining (P=.OOl) and
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treatment group (P=.007), were
found in the stepwise multipleregression analysis to be significantly
(P<.05) associated with the week-4
wound size. The fitted model from
this analysis indicates that the expected percentage of initial wound
size after 4 weeks would be 45.7%
(plus 43.2% if tunnels or undennining were present; minus 28.7% if they
received active stimulation). lhat is,
wounds would heal significantly less
well if tunnels or undermining were
present and significantly better if they
received active stimulation. As noted
previously, more of the wounds in
the treatment group than in the control group had tunnels or undennining, indicating that, if there was a bias
attributable to differences within the
treatment group, it was against the
active treatment.
For descriptive purposes only, we
categorized the 4-week results according to the following classification,
which did not lend itself to statistical
analysis: excellent results-wound
less than 25% of its initial size or
completely healed, good results-wound between 25% and 75% of its
initial size, and poor results-no
change or wound greater than 75% of
its initial size. Figure 3 shows that, at
4 weeks, a substantially higher proponion of the treatment group's
ulcers (92%) than of the control
group's ulcers (54%) could be categorized as good or excellent.

Founeen of the wound<> in the control
group were crossed over to nonrandomized active electrical stimulation
after the patients completed the 4
weeks of sham treatment (Tab. 4). Mter 4 weeks of sham treatment, these
14 wound<> were 88.7% of their initial
size and had healed at a rate of 2.9%
per week. After 4 weeks of active electrical stimulation, these same wound<>
were 49% of their size at the time of
crossover and had healed at a rate of
12.8% per week. The reduction in
wound size was fourfold greater after
receiving aaive stimulation (P=.OOS).
These wounds continued to be treated
for a mean total treaunent time of 10.8
weeks; all wounds except 2 continued
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T able 4. Summary of Wound Length-Width Products For Patients Who Crossed Over from Sham to Active Stimulation (n= 14)
Percentage of

Wound
No.

Total No. of Weeks
of Active

of Active Stimulation

Percentage of Wound Size at
Crossover After Last Week ot
Active Stimulation

Initial Size After 4

Percentage of Wound Size

Weeks of Sham
Treabnent

at Crossover After 4 Weeks

Stimulation

SH-01

90.00

66.66

37.03

10

SH-04

178.67

32.00

6.40

15

SH-06

83.59

26.37

000

7

SH-07

108.33

79.26

61.54

10

SH-08

139.59

98.25

85.96

7

SH-12

29.76

10.00

0.00

5

SH-13

37.65

36.46

47.40

8

SH-15

66.18

74.07

13.63

11

10

SH-16

28.13

17.78

0.00

SH-18

65.68

7.89

000

7

SH-19

142.01

52.50

0.00

13

SH-20

90.89

93.10

89.66

11

SH-22

81.71

76.92

79.25

16

SH-24

99.00

15.15

0.00

12

8

X

88.66'"

so

42.16

30.83

34 53

N

14

14

14

"Wounds

~ignificantly

49.03

smaller after a<-1ive stimulation thJn after sham treatment

to improve, and 43% (6/14) healed
completely.
After the 4-week double-blind portion
of the study, 17 of the actively treated
wounds continued to be treated. After
a mean of R weeks' total treaunent
time, the wounds had healed to
23.6% of their initial size, on average.
In addition, 3RS% (10!26) had healed
completely or nearly completely
(>95% healed) and 61.5% (16!26)
had healed more than 80%. The only
treaunent-related adverse effects reported were minor uncomfortable
sensations in the wound (ie, tingling),
which occurred in IS% of the patients
(10% of the control group and 20%
of the treatment group).

Dlacuaalon
The results of our study supported
our hypothesis and are in accord wilh
the results of olher studies 1__., showing
that electrical stimulation enhances
the r:ate and extent of healing of

20/647

10.80

30.06

(P=.OO'i~

3.07

14
t teM, one-tailed).

chronic wounds. Our findings are
also in accord with those of investigations demonstrating that electrical
stimulation can be used to promote
healing of acute wounds induced in
animals5· 7 ·8,19--- 2 l and to prevent necrosis from developing in ischemic skin
flaps in humans.3 1
We found that, after 4 weeks of treatment, wounds in the treatment group
healed to a mean of 44% of their initial size at a mean healing r:ate of 14%
a week. During the same period,
wounds in the control group healed
to a mean of 67% of their initial size
at a mean healing r:ate of 8.25% a
week. Our results suggest that Kloth
and Feedar were correct when they
stated that the electrical stimulation
treatment time required to satisfactorily enhance tissue healing does not
need to exceed 60 minutes per day, 5
to 7 days a week.4 This treatment time
is in contrast to the 20 to 42 hours of
elearical stimulation treatment per
week reported in other studies. 1-3 We

believe that treatment rimes between
the 3.7 hours per week reponed by
Kloth and Feedar4 and the 7 hours
per week reported in this study may
be beneficial.
Further evidence supporting the use
of pulsed electrical stimulation as
an efficacious treatment of chronic
wounds is provided by the 14 wounds
in the control group of this study that
were crossed over after 4 weeks to a
nonr:andomized active electrical stimulation treatment group. After 4
weeks of treatment, these wounds
healed at a mean rate of 12.8% a
week to 49% of their pretreatment
size. Kloth and Feedar reponed a similar response by a small group of
crossover wounds in a previous
study. 4
That wounds in the control group
healed to a mean of 67% of their initial size after 4 weeks is not surprising
to us, because each of these wounds
received an intensive amount of addi-
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tional care, including maintenance of
a moist wound microenvironment as
pan of the sham treatment Despite
the improvement of the control
group's wounds after 4 weeks, however, it b evident that the treatment
group's wounds benefited not only
from maintenance of a moist wound
environment, but also from the electrical stimulation. This treatment protocol very likely accounts for the fact
that 56% of the treatment group's
wound. demonstrated good healing
during the 4-week double-blind study
as compared with only 33% of the
control group's wounds.
We believe there is growing evidence
that exogenous electrical currents can
augment the healing process of dermal ulcers, perhaps by mimicking the
txxly's ovm bioelectrical signals. We
believe convincing evidence exists
that electrically augmented healing of
nonunion and delayed union fractures
is best facilitated by invasive cathodal
stimulation with between 5 and 20 ~
of direct current.32.33 K1oth and Feedar-! used a monophasic pulsedcurrent device to deliver ela:;trical
stimulation at a frequency of 105 pps
(342 j.LC/S) to wound tissue via the
anode for 45 minutes daily, 5 days a
week, and reponed complete healing
of nine wounds in a treatment group
in 7.3 weeks. In our study, we also
used a monophasic pulsed-current
device to initially deliver electrical
stimulation at a frequency of 128
pps (500 j.LC/s) via alternations of
cathode and anode every 3 days for
two 30-minute periods per day until
the wound healed to stage II. Thereafter, the frequency was reduced to
64 pps (250 p..C/s), because we believed the higher pulse frequency
might be harmful to the newly
healed tissue. Although the healing
rate of 14% a week after 4 weeks of
stimulation in this study appears
similar to the healing rates demonstrated in other studies,u we cannot
discern from our study what effect,
if any, the two different pulse frequencies had on the rates of healing
or the healing process.
Additional studies are needed to identify the mechanisms involved in the

promotion of wound healing with
electrical stimulation and to determine the stimulus variables that most
efficaciously accelerate tissue repair. It
is notewonhy that very few adverse
effectS attributable to electrical stimulation were reported during this
study. Those that were reponed were
minor and of little consequence.

Conclusion
The healing rate of 14% a week of
chronic wounds in the treatment
group falls within the range of 13%
to 46% reponed in the literature. Although one group received actual
electrical stimulation and the other
group received sham electrical stimulation, the groups' treatment protocols
were otherwise identical. We believe,
therefore, that the differences benveen the healing rates of the two
groups can be attributed to the electrical stimulation and that this study
documents that electrical stimulation
enhances healing of chronic ischemic
wounds. We conclude that the use of
electrical stimulation in the dosage
and manner used in this study is a
safe and effective way to treat stage II,
III, and N chronic dermal ulcers.
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